(19)
(11) EP 4 531 815 A1

(12)

(43) Date of publication:
09.04.2025 Bulletin 2025/15

(21) Application number: 22734111.2

(22) Date of filing: 27.05.2022
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
 A61K 31/4985(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0056; A61K 9/145; A61K 9/2013; A61K 31/4985
(86) International application number:
PCT/EP2022/000049
(87) International publication number:
WO 2023/227185 (30.11.2023 Gazette 2023/48)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • Rontis Hellas S.A.
    151 25 Marousi Athens (GR)
  • Pharos Ltd.
    144 52 Metamorfosiattikis (GR)

(72) Inventors:
  • GRYPIOTI, Agni
    Athens (GR)
  • PAPANDREOU, George
    Athens (GR)
  • TSITSAS, Panagiotis
    Athens (GR)

(74) Representative: Hamm&Wittkopp Patentanwälte PartmbB 
Jungfernstieg 38
20354 Hamburg
20354 Hamburg (DE)

   


(54) IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL AND NANOMILLING PROCESS FOR THE PREPARATION THEREOF